Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 5.30% vs -19.95% in Sep 2025
Standalone Net Profit
YoY Growth in quarter ended Sep 2026 is 34.31% vs -36.25% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is -19.32% vs -29.03% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is -7.94% vs 157.14% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Aarey Drugs With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 98.57% vs -76.44% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 5.30% vs -19.95% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 34.31% vs -34.62% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 34.31% vs -36.25% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 60.15% vs -69.35% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -19.32% vs -29.03% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -30.54% vs -6.18% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -7.94% vs 157.14% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025